Document is current
Any future updates will be listed below
-
Authors
Bloom, A. Joseph https://orcid.org/0000-0002-6731-5539
Mao, Xianrong
Strickland, Amy
Sasaki, Yo
Milbrandt, Jeffrey
DiAntonio, Aaron
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01NS119812)
National Institutes of Health (R01NS119812)
National Institutes of Health (R01NS119812)
National Institutes of Health (R01NS087632)
National Institutes of Health (R01NS087632)
National Institutes of Health (R37NS065053)
National Institutes of Health (RF1AG013730)
- License Information
-
More Information
Article History
Received: 15 September 2021
Accepted: 17 December 2021
First Online: 6 January 2022
Declarations
:
: All studies were approved by the Washington University Institutional Animal Care and Use Committee.
: Not Applicable.
: A.D. and J.M. are co-founders, scientific advisory board members and shareholders of Disarm Therapeutics, a wholly owned subsidiary of Eli Lilly. A.J.B. and Y.S. are consultants to Disarm Therapeutics. The authors have no other competing conflicts or financial interests.
